| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Electrophysiology | $428M | $527M | $649M | $730M | $840M | $865M | $890M | $905M |
| Endoscopy | $676M | $678M | $691M | $673M | $737M | $747M | $759M | $736M |
| Urology | $525M | $532M | $630M | $633M | $676M | $682M | $717M | $646M |
| Cardiac Rhythm Management | $576M | $561M | $566M | $578M | $590M | $578M | $586M | $578M |
| Watchman | $379M | $380M | $413M | $425M | $486M | $512M | $535M | $506M |
| Neuromodulation | $282M | $268M | $299M | $271M | $303M | $293M | $333M | $318M |
| Interventional Oncology & Embolization | — | — | — | — | — | — | — | $268M |
| Total | $4.12B | $4.21B | $4.56B | $4.66B | $5.06B | $5.07B | $5.29B | $5.2B |
Interventional Cardiology & Vascular Therapies is derived from annual filings.